TapewireFind a company

person · Reporting owner

Kamen Efrem

Disclosed activity across 4 companies

Tapewire entity
114373
SEC CIK
0001789193

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Greenlane Holdings, Inc.

Report date December 31, 2019 · Filed February 14, 2020

Jointly reported with PURA VIDA INVESTMENTS, LLC

Section 16 reporting ended · disclosed 2020-02-14. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common Stock, par value $0.01SEC Table I · non-derivativeIndirectBy Pura Vida Investments549,017 Reported balance After 2019-09-19 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2019-09-19 · Purchase · Acquired 35,000 · Balance 549,017

F1: Shares reported herein may be held by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida Pro Special Opportunity Master Fund, Ltd. (the "Pura Vida Pro Fund"), or certain separately managed accounts (the "Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Pura Vida Master Fund and the Accounts. Pura Vida Pro, LLC ("PVP") serves as the investment manager to the Pura Vida Pro Fund. PVP is a relying adviser of PVI. Efrem Kamen serves as the Managing Member of both PVI and PVP.

F3: This transaction was not previously reported due to the Adviser's inability to receive EDGAR access codes for one of its reporting persons. The filing deadline passed and the Adviser elected to report the transaction in a Form 5 filing.

F2: The securities reported herein may be deemed beneficially owned by each of: (i) PVI, which is deemed the beneficial owner of shares held by the Pura Vida Master Fund, the Pura Vida Pro Fund, and the Accounts (collectively, the "Client Accounts") in its capacity as investment manager on behalf of itself and PVP as its relying advisor, and (ii) Efrem Kamen who serves as the Managing Member of both PVI and PVP. Mr. Kamen exercises voting and dispositive control over the securities and is therefore deemed to be a beneficial owner of securities owned or controlled by PVI. Each of PVI and Mr. Kamen disclaim beneficial ownership of the reported securities held by the Client Accounts, except to the extent of its or his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Shares reported herein may be held by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida Pro Special Opportunity Master Fund, Ltd. (the "Pura Vida Pro Fund"), or certain separately managed accounts (the "Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Pura Vida Master Fund and the Accounts. Pura Vida Pro, LLC ("PVP") serves as the investment manager to the Pura Vida Pro Fund. PVP is a relying adviser of PVI. Efrem Kamen serves as the Managing Member of both PVI and PVP.

F2: The securities reported herein may be deemed beneficially owned by each of: (i) PVI, which is deemed the beneficial owner of shares held by the Pura Vida Master Fund, the Pura Vida Pro Fund, and the Accounts (collectively, the "Client Accounts") in its capacity as investment manager on behalf of itself and PVP as its relying advisor, and (ii) Efrem Kamen who serves as the Managing Member of both PVI and PVP. Mr. Kamen exercises voting and dispositive control over the securities and is therefore deemed to be a beneficial owner of securities owned or controlled by PVI. Each of PVI and Mr. Kamen disclaim beneficial ownership of the reported securities held by the Client Accounts, except to the extent of its or his pecuniary interest therein.

F3: This transaction was not previously reported due to the Adviser's inability to receive EDGAR access codes for one of its reporting persons. The filing deadline passed and the Adviser elected to report the transaction in a Form 5 filing.

Insight Molecular Diagnostics Inc.

Report date April 14, 2023 · Filed April 18, 2023

Jointly reported with PURA VIDA INVESTMENTS, LLC

Section 16 reporting ended · disclosed 2023-04-18. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Warrant to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.53 · Expires 2027-04-19IndirectBy the Managed Accounts517,245 Reported balance Holding disclosure · report date 2023-04-14 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance 517,245

F1: As of the reporting date, the Warrants are subject to an ownership blocker provision that prevents the Reporting Persons from exercising the Warrants if they would have voting and dispositive power for more than 9.99% of the common stock outstanding following such exercise.

F2: Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed account(s) (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.

F3: By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.

Warrant to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.53 · Expires 2027-04-19IndirectBy Pura Vida Master Fund, Ltd.832,949 Reported balance Holding disclosure · report date 2023-04-14 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance 832,949

F1: As of the reporting date, the Warrants are subject to an ownership blocker provision that prevents the Reporting Persons from exercising the Warrants if they would have voting and dispositive power for more than 9.99% of the common stock outstanding following such exercise.

F2: Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed account(s) (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.

F3: By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.

Warrant to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.53 · Expires 2027-04-19IndirectBy Pura Vida X Fund LP383,976 Reported balance Holding disclosure · report date 2023-04-14 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 383,976

F1: As of the reporting date, the Warrants are subject to an ownership blocker provision that prevents the Reporting Persons from exercising the Warrants if they would have voting and dispositive power for more than 9.99% of the common stock outstanding following such exercise.

F2: Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed account(s) (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.

F3: By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.

Warrant to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.53 · Expires 2027-04-19IndirectBy the Retirement Trust690,719 Reported balance Holding disclosure · report date 2023-04-14 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance 690,719

F1: As of the reporting date, the Warrants are subject to an ownership blocker provision that prevents the Reporting Persons from exercising the Warrants if they would have voting and dispositive power for more than 9.99% of the common stock outstanding following such exercise.

F2: Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed account(s) (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.

F3: By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: As of the reporting date, the Warrants are subject to an ownership blocker provision that prevents the Reporting Persons from exercising the Warrants if they would have voting and dispositive power for more than 9.99% of the common stock outstanding following such exercise.

F2: Securities reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed account(s) (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.

F3: By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.

MedMen Enterprises, Inc.

Report date August 17, 2021 · Filed April 29, 2022

Jointly reported with PURA VIDA INVESTMENTS, LLC, Pura Vida Master Fund, LTD

Section 16 reporting ended · disclosed 2022-04-29. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2028-08-17IndirectBy Pura Vida Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.34 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Senior Secured Convertible NoteSEC Table II · derivative / convertible security · Conversion / exercise price $0.28 · Expires 2028-08-17IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.Not disclosed Reported balance After 2021-08-17 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2021-08-17 · Other · Disposed Not disclosed · Balance Not disclosed

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.72 · Expires 2022-05-22IndirectBy Pura Vida Master Fund, LTD.234,753 Reported balance After 2021-08-17 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2021-08-17 · Other · Disposed 435,971 · Balance 234,753

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.29 · Expires 2022-05-22IndirectBy Pura Vida Master Fund, LTD.67,818 Reported balance After 2021-08-17 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2021-08-17 · Other · Disposed 125,947 · Balance 67,818

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2022-07-12IndirectBy Pura Vida Master Fund, LTD.69,074 Reported balance After 2021-08-17 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2021-08-17 · Other · Disposed 128,279 · Balance 69,074

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2022-07-12IndirectBy Pura Vida Master Fund, LTD.19,955 Reported balance After 2021-08-17 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2021-08-17 · Other · Disposed 37,058 · Balance 19,955

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2022-11-27IndirectBy Pura Vida Master Fund, LTD.86,322 Reported balance After 2021-08-17 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2021-08-17 · Other · Disposed 160,311 · Balance 86,322

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2022-11-27IndirectBy Pura Vida Master Fund, LTD.24,938 Reported balance After 2021-08-17 transaction · row 14 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 14 · 2021-08-17 · Other · Disposed 46,313 · Balance 24,938

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2025-03-27IndirectBy Pura Vida Master Fund, LTD.4,349,248 Reported balance After 2021-08-17 transaction · row 15 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 15 · 2021-08-17 · Other · Disposed 8,077,175 · Balance 4,349,248

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.72 · Expires 2022-05-22IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.74,132 Reported balance After 2021-08-17 transaction · row 16 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 16 · 2021-08-17 · Other · Disposed 137,675 · Balance 74,132

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.29 · Expires 2022-05-22IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.21,416 Reported balance After 2021-08-17 transaction · row 17 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 17 · 2021-08-17 · Other · Disposed 39,773 · Balance 21,416

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.16 · Expires 2022-07-12IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.21,813 Reported balance After 2021-08-17 transaction · row 18 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 18 · 2021-08-17 · Other · Disposed 40,509 · Balance 21,813

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $3.65 · Expires 2022-07-12IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.6,301 Reported balance After 2021-08-17 transaction · row 19 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 19 · 2021-08-17 · Other · Disposed 11,703 · Balance 6,301

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2022-11-27IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.27,259 Reported balance After 2021-08-17 transaction · row 20 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 20 · 2021-08-17 · Other · Disposed 50,625 · Balance 27,259

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2022-11-27IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.7,875 Reported balance After 2021-08-17 transaction · row 21 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 21 · 2021-08-17 · Other · Disposed 14,625 · Balance 7,875

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2025-03-27IndirectBy Pura Vida Pro Special Opportunity Master Fund, LTD.1,373,447 Reported balance After 2021-08-17 transaction · row 22 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 22 · 2021-08-17 · Other · Disposed 2,550,687 · Balance 1,373,447

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2: Currently exercisable.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F2: Currently exercisable.

F3: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F4: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

STRYVE FOODS, INC.

Report date September 15, 2021 · Filed September 17, 2021

Jointly reported with PURA VIDA INVESTMENTS, LLC

Section 16 reporting ended · disclosed 2021-09-17. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectSee footnote450,000 Reported balance After 2021-09-15 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2021-09-15 · Sale · Disposed 800,000 · Balance 450,000

F3: On September 15, 2021 (the "Effective Date"), the Issuer, Pura Vida and the Advisory Clients entered into that certain Share Purchase Agreement, pursuant to which the parties effected as of the Effective Date a simultaneous exchange of an aggregate of 800,000 shares of Common Stock held by the Advisory Clients for the Prepaid Warrants of the Issuer to purchase an aggregate of 800,000 shares of Common Stock.

F1: The shares of the Issuer's Class A Common Stock (the "Common Stock") reported herein were directly owned by certain private investment vehicles and accounts managed or sub-advised by Pura Vida Investments, LLC ("Pura Vida" and such private investment vehicles and accounts, the "Advisory Clients").

F6: The reported securities may be deemed beneficially owned by Pura Vida as investment manager or sub-adviser of the Advisory Clients. The reported securities may also be deemed beneficially owned by Efrem Kamen as the principal of Pura Vida. Each of Pura Vida and Mr. Kamen (the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Prepaid Common Stock Purchase Warrant (right to buy)SEC Table II · derivative / convertible securityIndirectSee footnote800,000 Reported balance After 2021-09-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-09-15 · Purchase · Acquired 800,000 · Balance 800,000

F5: Subject to the Beneficial Ownership Limitation, each Prepaid Warrant may be exercised at the option of the holder for no additional consideration. The Prepaid Warrants have no expiration date.

F3: On September 15, 2021 (the "Effective Date"), the Issuer, Pura Vida and the Advisory Clients entered into that certain Share Purchase Agreement, pursuant to which the parties effected as of the Effective Date a simultaneous exchange of an aggregate of 800,000 shares of Common Stock held by the Advisory Clients for the Prepaid Warrants of the Issuer to purchase an aggregate of 800,000 shares of Common Stock.

F4: The terms of each Prepaid Warrant provide that the holder of such Prepaid Warrant does not have the right to exercise, and the Issuer shall not effect any exercise of, any portion of such Prepaid Warrant to the extent that, after giving effect to the issuance of Common Stock after such exercise, the holder (together with such holder's affiliates, and any persons acting as a group together with such holder or affiliates) would beneficially own in excess of 9.99% of the shares of the Common Stock then issued and outstanding, which percentage may be changed at the holder's election upon 61 days' notice to the Issuer (the "Beneficial Ownership Limitation").

F2: The Prepaid Common Stock Purchase Warrants (the "Prepaid Warrants") reported herein are directly owned by the Advisory Clients.

F6: The reported securities may be deemed beneficially owned by Pura Vida as investment manager or sub-adviser of the Advisory Clients. The reported securities may also be deemed beneficially owned by Efrem Kamen as the principal of Pura Vida. Each of Pura Vida and Mr. Kamen (the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of the Issuer's Class A Common Stock (the "Common Stock") reported herein were directly owned by certain private investment vehicles and accounts managed or sub-advised by Pura Vida Investments, LLC ("Pura Vida" and such private investment vehicles and accounts, the "Advisory Clients").

F2: The Prepaid Common Stock Purchase Warrants (the "Prepaid Warrants") reported herein are directly owned by the Advisory Clients.

F3: On September 15, 2021 (the "Effective Date"), the Issuer, Pura Vida and the Advisory Clients entered into that certain Share Purchase Agreement, pursuant to which the parties effected as of the Effective Date a simultaneous exchange of an aggregate of 800,000 shares of Common Stock held by the Advisory Clients for the Prepaid Warrants of the Issuer to purchase an aggregate of 800,000 shares of Common Stock.

F4: The terms of each Prepaid Warrant provide that the holder of such Prepaid Warrant does not have the right to exercise, and the Issuer shall not effect any exercise of, any portion of such Prepaid Warrant to the extent that, after giving effect to the issuance of Common Stock after such exercise, the holder (together with such holder's affiliates, and any persons acting as a group together with such holder or affiliates) would beneficially own in excess of 9.99% of the shares of the Common Stock then issued and outstanding, which percentage may be changed at the holder's election upon 61 days' notice to the Issuer (the "Beneficial Ownership Limitation").

F5: Subject to the Beneficial Ownership Limitation, each Prepaid Warrant may be exercised at the option of the holder for no additional consideration. The Prepaid Warrants have no expiration date.

F6: The reported securities may be deemed beneficially owned by Pura Vida as investment manager or sub-adviser of the Advisory Clients. The reported securities may also be deemed beneficially owned by Efrem Kamen as the principal of Pura Vida. Each of Pura Vida and Mr. Kamen (the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 125,947 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 10

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 67,818

Underlying: Class B Subordinate Voting Shares · 193,765 shares

Expires 2022-05-22

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 435,971 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 9

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 234,753

Underlying: Class B Subordinate Voting Shares · 670,724 shares

Expires 2022-05-22

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.28 $50,567.99
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 236,991 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.34 $2,046,495.53
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 8,025,472 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.15 $1,503,749.88
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 13,113,144 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $1,101,959.13
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 8,642,816 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.28 $160,131.97
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 4

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 750,472 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.34 $6,480,570.00
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 3

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 25,414,000 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.15 $4,761,875.18
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 2

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 41,524,963 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
August 17, 2021 Filed Apr 29, 2022 20:45 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $3,489,537.69
Disclosure

SEC source: 0001209191-22-026285 · doc4.xml · derivative · entry 1

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 27,368,923 shares

Expires 2028-08-17

F1 · kind: In connection with the disposition of the securities, the parties entered into a Fourth Amended and Restated Securities Purchase Agreement dated August 17, 2021, pursuant to which amended and restated senior secured convertible notes (the "Notes") and warrants (the "Warrants") were issued. The maturity date on the Notes was changed from April 23, 2022 to August 17, 2028. As a result of the disposition of the Notes and Warrants, the Reporting Persons no longer beneficially own more than 10% of the Issuer's securities.

F3 · price: The Notes and Warrants reported on this Form 4 were sold for aggregate cash consideration of $6,251,483 plus an aggregate of 1,062,068 shares of common stock of Tilray, Inc., subject to adjustment.

F2 · derivative.exercise_date: Currently exercisable.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 1,259,035 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 1,259,035 shares

Expires 2026-01-11

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 506,250 Not disclosed Strike: $0.20 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 506,250 shares

Expires 2025-09-14

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 194,712 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 194,712 shares

Expires 2025-04-24

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 973,558 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 973,558 shares

Expires 2025-03-27

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,986,944 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 4

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 3,986,944 shares

Expires 2026-01-11

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 1,603,125 Not disclosed Strike: $0.20 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 3

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 1,603,125 shares

Expires 2025-09-14

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 616,587 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 2

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 616,587 shares

Expires 2025-04-24

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
April 21, 2021 Filed Apr 29, 2022 20:43 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,082,933 Not disclosed Strike: $0.26 Not disclosed
Disclosure

SEC source: 0001209191-22-026282 · doc4.xml · derivative · entry 1

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 3,082,933 shares

Expires 2025-03-27

F1 · kind: Warrant cancelled for no consideration pursuant to terms of the Third Amended and Restated Securities Purchase Agreement dated January 11, 2021.

F2 · price: Not applicable.

F3 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F4 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 1,259,035 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 24

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 1,259,035

Underlying: Class B Subordinate Voting Shares · 1,259,035 shares

Expires 2026-01-11

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F9 · kind: Warrant was issued pursuant to the Third Restatement. See also footnote (1).

F4 · price: Not applicable.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,214 Not disclosed Strike: $1.17 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 23

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 22,500

Underlying: Class B Subordinate Voting Shares · 25,714 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 11,127 Not disclosed Strike: $1.01 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 22

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 77,884

Underlying: Class B Subordinate Voting Shares · 89,011 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 2,572 Not disclosed Strike: $3.65 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 21

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 18,004

Underlying: Class B Subordinate Voting Shares · 20,576 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,903 Not disclosed Strike: $3.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 20

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 62,322

Underlying: Class B Subordinate Voting Shares · 71,225 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,741 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 19

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 61,189

Underlying: Class B Subordinate Voting Shares · 69,930 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 30,259 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 18

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 211,807

Underlying: Class B Subordinate Voting Shares · 242,066 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 3,986,944 Not disclosed Strike: $0.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 17

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 3,986,944

Underlying: Class B Subordinate Voting Shares · 3,986,944 shares

Expires 2026-01-11

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F9 · kind: Warrant was issued pursuant to the Third Restatement. See also footnote (1).

F4 · price: Not applicable.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 10,178 Not disclosed Strike: $1.17 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 16

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 71,250

Underlying: Class B Subordinate Voting Shares · 81,428 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 35,234 Not disclosed Strike: $1.01 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 15

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 246,633

Underlying: Class B Subordinate Voting Shares · 281,867 shares

Expires 2022-11-27

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 8,145 Not disclosed Strike: $3.65 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 14

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 57,013

Underlying: Class B Subordinate Voting Shares · 65,158 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 28,193 Not disclosed Strike: $3.16 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 13

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 197,353

Underlying: Class B Subordinate Voting Shares · 225,546 shares

Expires 2022-07-12

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 27,680 Not disclosed Strike: $4.29 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 12

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 193,765

Underlying: Class B Subordinate Voting Shares · 221,445 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherWarrant · Derivative 95,817 Not disclosed Strike: $3.72 Not disclosed
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 11

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 670,724

Underlying: Class B Subordinate Voting Shares · 766,541 shares

Expires 2022-05-22

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F8 · kind: Pursuant to the Third Restatement, a portion of the shares underlying this warrant was cancelled. See also footnote (1).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $1,403,716.39
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 10

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 8,257,155 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F7 · kind: This Note may be deemed issued for the purpose of Section 16 pursuant to the Third Restatement upon amendment of the conversion price of the original Notes. See also footnotes (1) and (2).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.78 $92,528.65
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 9

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 115,647 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $1.28 $174,678.90
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 132,700 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.17 $238,955.99
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 107,077 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.55 $897,552.85
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Opportunity Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 341,847 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.17 $4,445,120.46
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 26,147,767 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F7 · kind: This Note may be deemed issued for the purpose of Section 16 pursuant to the Third Restatement upon amendment of the conversion price of the original Notes. See also footnotes (1) and (2).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.78 $293,010.80
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 4

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 366,218 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $1.28 $553,156.25
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 3

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 420,217 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.17 $756,702.74
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 2

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 339,079 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
January 11, 2021 Filed Apr 29, 2022 20:42 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.55 $2,842,250.68
Disclosure

SEC source: 0001209191-22-026280 · doc4.xml · derivative · entry 1

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: 0

Underlying: Class B Subordinate Voting Shares · 1,082,518 shares

Expires 2022-04-23

F1 · security: Pursuant to a Third Amended and Restated Securities Purchase Agreement dated 01/11/2021 (the "Third Restatement"), (a) portions of certain warrants were cancelled, (b) additional share purchase warrants with an exercise price of $0.1608 per share were issued, and (c) the conversion prices of certain Senior Secured Convertible Notes (each a "Note" and collectively, the "Notes") were amended to $0.17 per share. Furthermore, Notes with conversion prices of $0.26 or $0.20 per share and warrants with an exercise price of $0.26 per share were automatically adjusted to $0.1529 pursuant to existing down-round adjustment provisions; such automatic adjustments are not required to be reported herein as they do not constitute acquisitions of additional securities. All dollar and share amounts of Notes reflect fully accreted principal amounts as of 01/11/2021. The ultimate number of shares issuable on conversion may vary based on the accrued interest payable on Notes at the time of any conversion.

F2 · kind: Pursuant to the Third Restatement, the conversion price of this Note was amended, which may be deemed a cancellation of the Note and an issuance of a new Note for the purpose of Section 16. See also footnotes (1) and (7).

F4 · price: Not applicable.

F3 · derivative.exercise_date: Currently exercisable as of Reporting Date.

F5 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F6 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the Shares reported herein except to the extent of the PVI's and Efrem Kamen's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.20 $12,311.10
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 8

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Oppportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 1,279,324 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.34 $128,035.44
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 7

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Oppportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 7,826,456 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.26 $36,933.30
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 6

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Oppportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 6,366,423 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.55 $68,942.16
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 5

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Pro Special Oppportunity Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 368,883 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.20 $38,985.15
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 4

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 4,051,194 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.34 $405,445.56
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 3

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 24,783,779 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $0.26 $116,955.45
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 2

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 20,160,339 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document
November 18, 2020 Filed Apr 29, 2022 20:41 UTC MedMen Enterprises, Inc. MMNFF · Entity 94628 OtherSenior Secured Convertible Note · Derivative Not disclosed Not disclosed Strike: $2.55 $218,316.84
Disclosure

SEC source: 0001209191-22-026278 · doc4.xml · derivative · entry 1

PURA VIDA INVESTMENTS, LLC · CIK 0001590144 · 10% owner

Pura Vida Master Fund, LTD · CIK 0001912371 · 10% owner

Kamen Efrem · CIK 0001789193 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Pura Vida Master Fund, LTD.

Disclosed balance after: Not disclosed

Underlying: Class B Subordinate Voting Shares · 1,168,132 shares

Expires 2022-04-23

F1 · kind: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F1 · price: On November 18, 2020, the Issuer made a partial prepayment on the Senior Secured Convertible Note (the "Note").

F2 · derivative.exercise_date: Currently exercisable.

F3 · derivative.underlying_shares: Represents the number of Class B Subordinate Voting Shares (the "Shares") issuable upon conversion of the outstanding principal amount of the Note prior to the partial prepayment on November 18, 2020. The ultimate number of Shares issuable upon conversion may vary based on the accrued interest payable on the Note at the time of conversion.

F4 · ownership.nature: The reporting persons (the "Reporting Persons") are Pura Vida Investments, LLC ("PVI"), Pura Vida Master Fund, LTD. (the "PV Master Fund"), and Efrem Kamen. PVI serves as the investment manager to the PV Master Fund. Pura Vida Pro, LLC ("PVP") serves as the investment manager to Pura Vida Pro Special Opportunity Master Fund, LTD. PVP is a relying adviser of PVI. Efrem Kamen serves as the managing member of both PVI and PVP.

F5 · ownership.nature: This Form 4 shall not be deemed an admission that PVI and Efrem Kamen are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of PVI and Efrem Kamen disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest, if any, therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.